FDA Recall D-0634-2022

STAQ Pharma, Inc. · Denver, CO

Class I — life-threatening Terminated 225 days on record

Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death.

Product

Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0105-04.

Lot / code: Lot Number: 21104221A, Expiration date: 05-22-2022

Quantity: n/a

Reason for recall

Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A

Recall record

Recall number: D-0634-2022
Classification: Class I
Status: Terminated
Voluntary or mandated: Voluntary: Firm initiated
Firm notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution: CO, OH, and TX.
Recall initiated: 2022-02-03
Classified by FDA Center: 2022-02-25
FDA published: 2022-02-23
Terminated: 2022-09-16
Recalling firm: STAQ Pharma, Inc.
Firm location: Denver, CO

‹ All recalls